Dorui pharmaceutical: clinical approval documents for subsidiaries to purchase new drugs
Dorui pharmaceutical announced that ruidilian pharmaceutical, a holding subsidiary, signed a technology transfer contract with Henan University of traditional Chinese medicine, which agreed that Henan University of traditional Chinese medicine would transfer all patents and non patented technologies related to the clinical trial approval notice of "Yifei Jisheng Granule" and its new drug projects to ruidilian pharmaceutical.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Staples, Financials, Technology
EqualOcean Founding Partner Yuanpu Huang: Long China, a New Playbook in New Era
On November 10, Yuanpu Huang, the Founding Partner EqualOcean, was invited by China Creation Ventures (CCV) to give a speech on Long China, a New Playbook in New Era in English. He believes that Go Global will be the opportunity of the times for Chinese companies. Here we present the edited transcript.
Nov 12, 2023 09:16 PM
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Nov 08, 2022 08:32 AM
Nov 07, 2022 04:27 PM
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Insight
In-depth